Galmed Pharmaceuticals
GLMD
GLMD
44 hedge funds and large institutions have $102M invested in Galmed Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.13% more ownership
Funds ownership: 0.1% → 0.23% (+0.13%)
Holders
44
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$21M | |
| 2 | +$9.43M | |
| 3 | +$8.34M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$7.57M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$7.45M |
Top Sellers
| 1 | -$2.03M | |
| 2 | -$500K | |
| 3 | -$398K | |
| 4 |
JGC
J. Goldman & Co
New York
|
-$145K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$107K |